HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER

Clinical trials for HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER explained in plain language.

Never miss a new study

Get alerted when new HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER trials appear

Sign up with your email to follow new studies for HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New drug cocktail could rival standard bladder cancer therapy in major trial

Disease control Ongoing

This study tests whether a combination of two chemotherapy drugs (gemcitabine and docetaxel, or GEMDOCE) works as well as the standard BCG treatment for people with a high-grade, non-muscle invasive bladder cancer that hasn't been treated before. About 870 adults will be randomly…

Matched conditions: HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER

Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Jun 09, 2026 12:08 UTC

HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER

Get alerted when new HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER trials appear

New drug cocktail could rival standard bladder cancer therapy in major trial